tradingkey.logo
搜索

Rapid Micro Biosystems Inc

RPID
添加自选
2.130USD
+0.020+0.95%
收盘 07-31 16:00美东报价延迟15分钟
97.48M总市值
亏损市盈率 TTM

关于 Rapid Micro Biosystems Inc 公司

Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission-critical automation solutions to facilitate the manufacturing and release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.

Rapid Micro Biosystems Inc简介

公司代码RPID
公司名称Rapid Micro Biosystems Inc
上市日期Jul 15, 2021
CEOSpignesi (Robert)
员工数量163
证券类型Ordinary Share
年结日Jul 15
公司地址25 Hartwell Avenue
城市LEXINGTON
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编02421
电话19783493200
网址https://www.rapidmicrobio.com/
公司代码RPID
上市日期Jul 15, 2021
CEOSpignesi (Robert)

Rapid Micro Biosystems Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Richard S. Kollender
Mr. Richard S. Kollender
Independent Director
Independent Director
116.02K
+16.64%
Ms. Inese Lowenstein
Ms. Inese Lowenstein
Independent Director
Independent Director
56.39K
+56.90%
Mr. Natale S. (Nat) Ricciardi
Mr. Natale S. (Nat) Ricciardi
Independent Director
Independent Director
15.14K
-94.44%
Mr. Robert (Rob) Spignesi
Mr. Robert (Rob) Spignesi
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Sean M. Wirtjes, CPA
Mr. Sean M. Wirtjes, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Mr. John Wilson
Mr. John Wilson
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Kirk D. Malloy, Ph.D.
Dr. Kirk D. Malloy, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. James Xu
Mr. James Xu
Senior Vice President - Legal, Company Secretary
Senior Vice President - Legal, Company Secretary
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Richard S. Kollender
Mr. Richard S. Kollender
Independent Director
Independent Director
116.02K
+16.64%
Ms. Inese Lowenstein
Ms. Inese Lowenstein
Independent Director
Independent Director
56.39K
+56.90%
Mr. Natale S. (Nat) Ricciardi
Mr. Natale S. (Nat) Ricciardi
Independent Director
Independent Director
15.14K
-94.44%
Mr. Robert (Rob) Spignesi
Mr. Robert (Rob) Spignesi
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Sean M. Wirtjes, CPA
Mr. Sean M. Wirtjes, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--

常见问题

Rapid Micro Biosystems Inc的前五大股东是谁?

Rapid Micro Biosystems Inc 的前五大股东如下:Mr. Richard S. Kollender

有多少机构持有Rapid Micro Biosystems Inc(RPID)的股份?

截至2026Q1,共有67家机构持有Rapid Micro Biosystems Inc的股份,合计持有的股份价值约为25.08M,占公司总股份的60.78%。与2025Q4相比,机构持股有所增加,增幅为607827.00。

哪个业务部门对Rapid Micro Biosystems Inc的收入贡献最大?

在2026Q1,Product revenue业务部门对Rapid Micro Biosystems Inc的收入贡献最大,创收23.43M,占总收入的69.75%。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有